These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15711018)

  • 21. Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance.
    Hensel KO
    Med Hypotheses; 2016 Sep; 94():7-10. PubMed ID: 27515189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex steroid hormones in diabetes-induced sexual dysfunction: focus on the female gender.
    Kim NN
    J Sex Med; 2009 Mar; 6 Suppl 3():239-46. PubMed ID: 19267847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary vascular dysfunction in premenopausal women with diabetes mellitus.
    Di Carli MF; Afonso L; Campisi R; Ramappa P; Bianco-Batlles D; Grunberger G; Schelbert HR
    Am Heart J; 2002 Oct; 144(4):711-8. PubMed ID: 12360169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes.
    Joshi D; Gupta R; Dubey A; Shiwalkar A; Pathak P; Gupta RC; Chauthaiwale V; Dutt C
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):72-81. PubMed ID: 19546815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.
    Venskutonyte L; Malmberg K; Norhammar A; Wedel H; Rydén L
    J Intern Med; 2010 Jul; 268(1):75-82. PubMed ID: 20210844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
    Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
    Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus.
    Gonçalves N; Gomes-Ferreira C; Moura C; Roncon-Albuquerque R; Leite-Moreira AF; Falcão-Pires I
    Int J Cardiol; 2016 Aug; 217():195-204. PubMed ID: 27195451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.
    Kautzky-Willer A; Harreiter J; Pacini G
    Endocr Rev; 2016 Jun; 37(3):278-316. PubMed ID: 27159875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The late complications of diabetes mellitus.
    Squadrito G; Cucinotta D
    Ann Ital Med Int; 1991; 6(1 Pt 2):126-36. PubMed ID: 1742148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.
    Toedebusch R; Belenchia A; Pulakat L
    Front Physiol; 2018; 9():453. PubMed ID: 29773993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Energy metabolism and contractile function of the heart in diabetic cardiomyopathy: effect of ischemia and reperfusion].
    Dzhavadov SA; Dzhokharidze TZ; Dzhaliashvili IV; Gel'fgat EB; Saks VA; Pogacha G
    Biokhimiia; 1992 Dec; 57(12):1917-29. PubMed ID: 1294259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipotoxicity in type 2 diabetic cardiomyopathy.
    van de Weijer T; Schrauwen-Hinderling VB; Schrauwen P
    Cardiovasc Res; 2011 Oct; 92(1):10-8. PubMed ID: 21803867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heart failure--are there gender aspects?].
    Regitz-Zagrosek V; Lehmkuhl E; Lehmkuhl HB
    Internist (Berl); 2008 Apr; 49(4):422-6, 428. PubMed ID: 18301870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy.
    Ussher JR
    Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland.
    Tuomilehto J; Borch-Johnsen K; Molarius A; Forsén T; Rastenyte D; Sarti C; Reunanen A
    Diabetologia; 1998 Jul; 41(7):784-90. PubMed ID: 9686919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in diabetes and operative risk.
    Rossi E
    Rays; 1997; 22(4):595-602. PubMed ID: 9550900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 study.
    Jensen MT; Sogaard P; Andersen HU; Bech J; Fritz Hansen T; Biering-Sørensen T; Jørgensen PG; Galatius S; Madsen JK; Rossing P; Jensen JS
    JACC Cardiovasc Imaging; 2015 Apr; 8(4):400-410. PubMed ID: 25746329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study.
    Di Bello V; Talarico L; Picano E; Di Muro C; Landini L; Paterni M; Matteucci E; Giusti C; Giampietro O
    J Am Coll Cardiol; 1995 May; 25(6):1408-15. PubMed ID: 7722141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.